U.S. Physical Therapy, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-92.9% vs price
Base Case (Median)
-68.7% vs price
Bull Case (75th pct.)
-18.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $2.40 | -96.9% | High (40%) |
| PE Comparable | $3.78 | -95.2% | Medium (25%) |
| Graham Number | $10.96 | -86.0% | Medium (40%) |
| EV/EBITDA | $72.27 | -7.9% | Medium (20%) |
| EV/FCF | $84.44 | 7.6% | Medium (20%) |
| Earnings Power Value | $38.19 | -51.3% | Medium (50%) |
Based on 6 out of 8 methods, USPH appears overvalued at the current price of $78.48. The base case fair value of $24.57 implies 68.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.